Clinical Trial Update: Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 dose-ranging trial of etrasimod versus placebo as induction therapy in adult Japanese patients with moderately to severely active ulc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Etrasimod (etrasimod)

Snippet

Sponsor: Pfizer | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2024-10-29